LifeStance Health LFST 深 沪
已收盘 10-16 16:00:00 美东时间
11.74
-0.630
-5.09%
华盛通- 最 高12.49
- 今 开12.45
- 成交量 282.49万股
- 最 低 11.68
- 昨 收 12.37
- 总市值 44.63亿
- 52周最高 13.56
- 市盈率 静 475.30
- 换手率 0.74%
- 52周最低 4.77
- 委 比 -94.09%
- 总股本 3.80亿
- 历史最高 29.811
- 量 比 1.10
- 振 幅 6.55%
- 历史最低 3.74
- 每 手 1
- 风险率 2.42%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多LifeStance Health Board Member Announces Planned Year-End Resignation
Lifestance Health Group ( ($LFST) ) has issued an announcement. LifeStance Heal...
今天 05:49
Hospital group files lawsuit to stop 340B rebate pilot again
The American Hospital Association has once again filed a lawsuit to halt a new pilot that tests a revised rebate model for the 340B Drug Pricing Program, a federal benefits program for underinsured an...
10-10 22:57
美股大行评级 | 瑞银维持康宁“买入”评级，上调目标价至201美元；大摩维持泛林集团“超配”评级
今日重点评级关注：Needham：维持iRhythm Holdings"买入"评级，目标价从192美元升至194美元；HC Wainwright & Co.：维持5E Advanced Materials"买入"评级，目标价从3.5美元升至6.75美元
10-06 16:45
Keybanc Maintains Overweight on LifeStance Health Gr, Raises Price Target to $15
Keybanc analyst Steve Dechert maintains LifeStance Health Gr (NASDAQ:LFST) with a Overweight and raises the price target from $13 to $15.
10-05 20:21
美股大行评级 | 齐声看好医药股！礼来、强生、默沙东目标价均获上调；小摩大幅上调Meta目标价至820美元
今日重点评级关注：康托·菲茨杰拉德：维持SOL Strategies"超配"评级，目标价从2.8美元升至6.2美元；康托·菲茨杰拉德：维持Sui Group Holdings"超配"评级，目标价从1.7美元升至3.4美元
09-11 14:30
美股大行评级 | 戴尔、Adobe获大行上调目标价；甲骨文绩前目标价遭调低
今日重点评级关注：富国银行：维持Pyxis Oncology"超配"评级，目标价从12美元升至19美元；Oppenheimer：维持Opus Genetics"跑赢大市"评级，目标价从10美元升至20美元
09-10 15:00
Canaccord Genuity Maintains Buy on LifeStance Health Gr, Raises Price Target to $15
Canaccord Genuity analyst Richard Close maintains LifeStance Health Gr (NASDAQ:LFST) with a Buy and raises the price target from $13 to $15.
09-10 02:29
LifeStance Prices 22.25M Share Secondary Offering At $12.35/Share; Co To Repurchase 2M Shares
LifeStance Health Group, Inc. ("LifeStance" or the "Company") (NASDAQ:LFST), one of the nation’s largest providers of virtual and in-person outpatient mental health care, today announced the pricing of a secondary underwritten public offering of 22,250,000 shares of LifeStance’s common stock, par va...
09-09 21:17
LifeStance Health Group files secondary offering of 22.25M shares
LifeStance Health Group's (LFST) stockholders intend to offer 22.25M shares of the company's common stock, par value $0.01 per share. The selling stockholders will receive all the proceeds from the of...
09-09 20:15
LifeStance Health Group Announces Launch of Secondary Public Offering
LifeStance Health Group announced that certain stockholders plan to offer 22,250,000 shares of its common stock, with the Company not participating in the sale. Concurrently, LifeStance has authorized the repurchase of 2,000,000 shares from the underwriter at the same price as the offering, with no underwriting fees for the repurchased shares. Barclays is acting as the underwriter. The offering is subject to customary conditions and not condition...
09-09 11:00
